Peri-Implantation Lethality in Mice Carrying Megabase-Scale Deletion
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Open Dogan Phdthesis Final.Pdf
The Pennsylvania State University The Graduate School Eberly College of Science ELUCIDATING BIOLOGICAL FUNCTION OF GENOMIC DNA WITH ROBUST SIGNALS OF BIOCHEMICAL ACTIVITY: INTEGRATIVE GENOME-WIDE STUDIES OF ENHANCERS A Dissertation in Biochemistry, Microbiology and Molecular Biology by Nergiz Dogan © 2014 Nergiz Dogan Submitted in Partial Fulfillment of the Requirements for the Degree of Doctor of Philosophy August 2014 ii The dissertation of Nergiz Dogan was reviewed and approved* by the following: Ross C. Hardison T. Ming Chu Professor of Biochemistry and Molecular Biology Dissertation Advisor Chair of Committee David S. Gilmour Professor of Molecular and Cell Biology Anton Nekrutenko Professor of Biochemistry and Molecular Biology Robert F. Paulson Professor of Veterinary and Biomedical Sciences Philip Reno Assistant Professor of Antropology Scott B. Selleck Professor and Head of the Department of Biochemistry and Molecular Biology *Signatures are on file in the Graduate School iii ABSTRACT Genome-wide measurements of epigenetic features such as histone modifications, occupancy by transcription factors and coactivators provide the opportunity to understand more globally how genes are regulated. While much effort is being put into integrating the marks from various combinations of features, the contribution of each feature to accuracy of enhancer prediction is not known. We began with predictions of 4,915 candidate erythroid enhancers based on genomic occupancy by TAL1, a key hematopoietic transcription factor that is strongly associated with gene induction in erythroid cells. Seventy of these DNA segments occupied by TAL1 (TAL1 OSs) were tested by transient transfections of cultured hematopoietic cells, and 56% of these were active as enhancers. Sixty-six TAL1 OSs were evaluated in transgenic mouse embryos, and 65% of these were active enhancers in various tissues. -
Multidrug Transporter MRP4/ABCC4 As a Key Determinant of Pancreatic
www.nature.com/scientificreports OPEN Multidrug transporter MRP4/ ABCC4 as a key determinant of pancreatic cancer aggressiveness A. Sahores1, A. Carozzo1, M. May1, N. Gómez1, N. Di Siervi1, M. De Sousa Serro1, A. Yanef1, A. Rodríguez‑González2, M. Abba3, C. Shayo2 & C. Davio1* Recent fndings show that MRP4 is critical for pancreatic ductal adenocarcinoma (PDAC) cell proliferation. Nevertheless, the signifcance of MRP4 protein levels and function in PDAC progression is still unclear. The aim of this study was to determine the role of MRP4 in PDAC tumor aggressiveness. Bioinformatic studies revealed that PDAC samples show higher MRP4 transcript levels compared to normal adjacent pancreatic tissue and circulating tumor cells express higher levels of MRP4 than primary tumors. Also, high levels of MRP4 are typical of high-grade PDAC cell lines and associate with an epithelial-mesenchymal phenotype. Moreover, PDAC patients with high levels of MRP4 depict dysregulation of pathways associated with migration, chemotaxis and cell adhesion. Silencing MRP4 in PANC1 cells reduced tumorigenicity and tumor growth and impaired cell migration. Transcriptomic analysis revealed that MRP4 silencing alters PANC1 gene expression, mainly dysregulating pathways related to cell-to-cell interactions and focal adhesion. Contrarily, MRP4 overexpression signifcantly increased BxPC-3 growth rate, produced a switch in the expression of EMT markers, and enhanced experimental metastatic incidence. Altogether, our results indicate that MRP4 is associated with a more aggressive phenotype in PDAC, boosting pancreatic tumorigenesis and metastatic capacity, which could fnally determine a fast tumor progression in PDAC patients. Pancreatic ductal adenocarcinoma (PDAC) is one of the most lethal human malignancies, due to its late diag- nosis, inherent resistance to treatment and early dissemination 1. -
Phosducin Regulates Transmission at the Photoreceptor-To-ON-Bipolar Cell Synapse
The Journal of Neuroscience, March 3, 2010 • 30(9):3239–3253 • 3239 Cellular/Molecular Phosducin Regulates Transmission at the Photoreceptor-to-ON-Bipolar Cell Synapse Rolf Herrmann,1 Ekaterina S. Lobanova,1 Timothy Hammond,1 Christopher Kessler,2 Marie E. Burns,2 Laura J. Frishman,3 and Vadim Y. Arshavsky1 1Albert Eye Research Institute, Duke University, Durham, North Carolina 27710, 2Center for Neuroscience and Department of Ophthalmology and Vision Science, University of California Davis, Davis, California 95618, and 3College of Optometry, University of Houston, Houston, Texas 77204 The rate of synaptic transmission between photoreceptors and bipolar cells has been long known to depend on conditions of ambient illumination. However, the molecular mechanisms that mediate and regulate transmission at this ribbon synapse are poorly understood. We conducted electroretinographic recordings from dark- and light-adapted mice lacking the abundant photoreceptor-specific protein phosducin and found that the ON-bipolar cell responses in these animals have a reduced light sensitivity in the dark-adapted state. Additional desensitization of their responses, normally caused by steady background illumination, was also diminished compared with wild-type animals. This effect was observed in both rod- and cone-driven pathways, with the latter affected to a larger degree. The underlying mechanism is likely to be photoreceptor specific because phosducin is not expressed in other retina neurons and transgenic expression of phosducin in rods of phosducin knock-out mice rescued the rod-specific phenotype. The underlying mechanism functions downstream from the phototransduction cascade, as evident from the sensitivity of phototransduction in phosducin knock-out rods being affected to a much lesser degree than b-wave responses. -
Genomic Discovery of an Evolutionarily Programmed Modality for Small-Molecule Targeting of an Intractable Protein Surface
Genomic discovery of an evolutionarily programmed modality for small-molecule targeting of an intractable protein surface Uddhav K. Shigdela,1,2, Seung-Joo Leea,1,3, Mathew E. Sowaa,1,4, Brian R. Bowmana,1,5, Keith Robisona,6, Minyun Zhoua,7, Khian Hong Puaa,8, Dylan T. Stilesa,6, Joshua A. V. Blodgetta,9, Daniel W. Udwarya,10, Andrew T. Rajczewskia,11, Alan S. Manna,12, Siavash Mostafavia,13, Tara Hardyb, Sukrat Aryab,14, Zhigang Wenga,15, Michelle Stewarta,16, Kyle Kenyona,6, Jay P. Morgensterna,6, Ende Pana,17, Daniel C. Graya,6, Roy M. Pollocka,4, Andrew M. Fryb, Richard D. Klausnerc,18, Sharon A. Townsona,19, and Gregory L. Verdinea,d,e,f,2,18,20 Contributed by Richard D. Klausner, April 21, 2020 (sent for review April 8, 2020; reviewed by Chuan He and Ben Shen) The vast majority of intracellular protein targets are refractory toward small-molecule therapeutic engagement, and additional Author contributions: U.K.S., S.-J.L., M.E.S., B.R.B., K.R., Z.W., M.S., D.C.G., R.M.P., A.M.F., R.D.K., S.A.T., and G.L.V. designed research; U.K.S., S.-J.L., M.E.S., K.R., M.Z., K.H.P., D.T.S., therapeutic modalities are needed to overcome this deficiency. J.A.V.B., D.W.U., A.T.R., A.S.M., S.M., T.H., S.A., K.K., J.P.M., E.P., R.D.K., and G.L.V. performed Here, the identification and characterization of a natural product, research; M.E.S., D.T.S., and A.M.F. -
Polo-Like Kinase 1 Regulates Nlp, a Centrosome Protein Involved in Microtubule Nucleation
View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Elsevier - Publisher Connector Developmental Cell, Vol. 5, 113–125, July, 2003, Copyright 2003 by Cell Press Polo-like Kinase 1 Regulates Nlp, a Centrosome Protein Involved in Microtubule Nucleation Martina Casenghi,1,2 Patrick Meraldi,1,2,3 Rieder, 1999; Palazzo et al., 2000). Although centrosome Ulrike Weinhart,1 Peter I. Duncan,1,4 maturation is important for mitotic spindle formation, the Roman Ko¨ rner,1 and Erich A. Nigg1,* underlying mechanisms remain largely unknown. Two 1Department of Cell Biology protein kinases, Polo-like kinase 1 (Plk1; Lane and Nigg, Max Planck Institute of Biochemistry 1996; Sunkel and Glover, 1988) and Aurora-A (Berdnik Am Klopferspitz 18a and Knoblich, 2002; Hannak et al., 2001), as well as D-82152 Martinsried protein phosphatase 4 (Helps et al., 1998; Sumiyoshi Germany et al., 2002), have been implicated in the regulation of centrosome maturation, but the substrates of these en- zymes await identification. Also acting at the G2/M tran- sition, the protein kinase Nek2 and a member of the Summary phosphatase 1 family contribute to regulate centrosome separation, in part through phosphorylation of the centri- In animal cells, most microtubules are nucleated at ole-associated protein C-Nap1 (Fry et al., 1998b; Helps centrosomes. At the onset of mitosis, centrosomes et al., 2000; Mayor et al., 2000). undergo a structural reorganization, termed matura- The discovery of ␥-tubulin and ␥-tubulin-containing tion, which leads to increased microtubule nucleation multiprotein complexes has greatly advanced our un- activity. -
Pan-Cancer Analysis of Homozygous Deletions in Primary Tumours Uncovers Rare Tumour Suppressors
Corrected: Author correction; Corrected: Author correction ARTICLE DOI: 10.1038/s41467-017-01355-0 OPEN Pan-cancer analysis of homozygous deletions in primary tumours uncovers rare tumour suppressors Jiqiu Cheng1,2, Jonas Demeulemeester 3,4, David C. Wedge5,6, Hans Kristian M. Vollan2,3, Jason J. Pitt7,8, Hege G. Russnes2,9, Bina P. Pandey1, Gro Nilsen10, Silje Nord2, Graham R. Bignell5, Kevin P. White7,11,12,13, Anne-Lise Børresen-Dale2, Peter J. Campbell5, Vessela N. Kristensen2, Michael R. Stratton5, Ole Christian Lingjærde 10, Yves Moreau1 & Peter Van Loo 3,4 1234567890 Homozygous deletions are rare in cancers and often target tumour suppressor genes. Here, we build a compendium of 2218 primary tumours across 12 human cancer types and sys- tematically screen for homozygous deletions, aiming to identify rare tumour suppressors. Our analysis defines 96 genomic regions recurrently targeted by homozygous deletions. These recurrent homozygous deletions occur either over tumour suppressors or over fragile sites, regions of increased genomic instability. We construct a statistical model that separates fragile sites from regions showing signatures of positive selection for homozygous deletions and identify candidate tumour suppressors within those regions. We find 16 established tumour suppressors and propose 27 candidate tumour suppressors. Several of these genes (including MGMT, RAD17, and USP44) show prior evidence of a tumour suppressive function. Other candidate tumour suppressors, such as MAFTRR, KIAA1551, and IGF2BP2, are novel. Our study demonstrates how rare tumour suppressors can be identified through copy number meta-analysis. 1 Department of Electrical Engineering (ESAT) and iMinds Future Health Department, University of Leuven, Kasteelpark Arenberg 10, B-3001 Leuven, Belgium. -
Estimation of Non-Null SNP Effect Size Distributions Enables the Detection
bioRxiv preprint doi: https://doi.org/10.1101/597484; this version posted May 13, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. 1 1 Estimation of Non-null SNP Effect Size Distributions Enables 2 the Detection of Enriched Genes Underlying Complex Traits 3 1,2 1,2 2-4 4 Wei Cheng , Sohini Ramachandran y, and Lorin Crawford y 5 1 Department of Ecology and Evolutionary Biology, Brown University, Providence, RI, 6 USA 7 2 Center for Computational Molecular Biology, Brown University, Providence, RI, USA 8 3 Department of Biostatistics, Brown University, Providence, RI, USA 9 4 Center for Statistical Sciences, Brown University, Providence, RI, USA 10 Corresponding E-mail: [email protected]; lorin [email protected] y 11 Abstract 12 Traditional univariate genome-wide association studies generate false positives and negatives due to 13 difficulties distinguishing associated variants from variants with spurious nonzero effects that do not 14 directly influence the trait. Recent efforts have been directed at identifying genes or signaling pathways 15 enriched for mutations in quantitative traits or case-control studies, but these can be computationally 16 costly and hampered by strict model assumptions. Here, we present gene-", a new approach for identifying 17 statistical associations between sets of variants and quantitative traits. Our key insight is that enrichment 18 studies on the gene-level are improved when we reformulate the genome-wide SNP-level null hypothesis 19 to identify spurious small-to-intermediate SNP effects and classify them as non-causal. -
CENTROSOME NUMBER HOMEOSTASIS: LESSONS from CEP135 ISOFORM DYSREGULATION in BREAST CANCER by DIVYA GANAPATHI SANKARAN Bachelor
CENTROSOME NUMBER HOMEOSTASIS: LESSONS FROM CEP135 ISOFORM DYSREGULATION IN BREAST CANCER By DIVYA GANAPATHI SANKARAN Bachelor of Technology, Anna University, India, 2013 A thesis submitted to the Faculty of the Graduate School of the University of Colorado in partial fulfillment of the requirements for the degree of Doctor of Philosophy Cancer Biology Program 2019 This thesis for the Doctor of Philosophy degree by Divya Ganapathi Sankaran has been approved for the Cancer Biology Program By Rytis Prekeris, Chair Jeffrey Moore David Bentley Heide Ford Mary Reyland Chad G Pearson, Advisor Date: 05/17/2019 ii Ganapathi Sankaran, Divya (Ph.D., Cancer Biology) Centrosome Number Homeostasis: Lessons from CEP135 Isoform Dysregulation in Breast Cancer Thesis Directed by Associate Professor Chad G. Pearson ABSTRACT The centrosome, comprised of two centrioles surrounded by pericentriolar material, is the cell’s central microtubule organizing center. Centrosome duplication is coupled with the cell cycle such that centrosomes duplicate once in S phase. Loss of such coupling produces supernumerary centrosomes, a condition called centrosome amplification (CA). CA can promote hallmarks of tumorigenesis. In this thesis, I investigate the contribution of centriole overduplication to CA and its consequences on microtubule organization and genomic stability in breast cancer cells. CEP135, a centriole assembly protein, is dysregulated in some breast cancers. We previously identified a short isoform of CEP135, CEP135mini that represses centriole duplication. CEP135mini represses centriole duplication by limiting the localization of essential proteins required for centriole duplication. Interestingly, the relative level of CEP135full to CEP135mini (the CEP135full:mini ratio) is higher in centrosome amplified breast cancer cell lines. -
Role and Regulation of the P53-Homolog P73 in the Transformation of Normal Human Fibroblasts
Role and regulation of the p53-homolog p73 in the transformation of normal human fibroblasts Dissertation zur Erlangung des naturwissenschaftlichen Doktorgrades der Bayerischen Julius-Maximilians-Universität Würzburg vorgelegt von Lars Hofmann aus Aschaffenburg Würzburg 2007 Eingereicht am Mitglieder der Promotionskommission: Vorsitzender: Prof. Dr. Dr. Martin J. Müller Gutachter: Prof. Dr. Michael P. Schön Gutachter : Prof. Dr. Georg Krohne Tag des Promotionskolloquiums: Doktorurkunde ausgehändigt am Erklärung Hiermit erkläre ich, dass ich die vorliegende Arbeit selbständig angefertigt und keine anderen als die angegebenen Hilfsmittel und Quellen verwendet habe. Diese Arbeit wurde weder in gleicher noch in ähnlicher Form in einem anderen Prüfungsverfahren vorgelegt. Ich habe früher, außer den mit dem Zulassungsgesuch urkundlichen Graden, keine weiteren akademischen Grade erworben und zu erwerben gesucht. Würzburg, Lars Hofmann Content SUMMARY ................................................................................................................ IV ZUSAMMENFASSUNG ............................................................................................. V 1. INTRODUCTION ................................................................................................. 1 1.1. Molecular basics of cancer .......................................................................................... 1 1.2. Early research on tumorigenesis ................................................................................. 3 1.3. Developing -
Characterization of NIP2/Centrobin, a Novel Substrate of Nek2, and Its Potential Role in Microtubule Stabilization
2106 Research Article Characterization of NIP2/centrobin, a novel substrate of Nek2, and its potential role in microtubule stabilization Yeontae Jeong, Jungmin Lee, Kyeongmi Kim, Jae Cheal Yoo and Kunsoo Rhee* Department of Biological Sciences and Research Center for Functional Cellulomics, Seoul National University, Seoul 151-742, Korea *Author for correspondence (e-mail: [email protected]) Accepted 11 April 2007 Journal of Cell Science 120, 2106-2116 Published by The Company of Biologists 2007 doi:10.1242/jcs.03458 Summary Nek2 is a mitotic kinase whose activity varies during the associated with microtubules. Knockdown of NIP2 showed cell cycle. It is well known that Nek2 is involved in significant reduction of microtubule organizing activity, centrosome splitting, and a number of studies have cell shrinkage, defects in spindle assembly and abnormal indicated that Nek2 is crucial for maintaining the integrity nuclear morphology. Based on our results, we propose that of centrosomal structure and microtubule nucleation NIP2 has a role in stabilizing the microtubule structure. activity. In the present study, we report that NIP2, Phosphorylation may be crucial for mobilization of the previously identified as centrobin, is a novel substrate of protein to a new microtubule and stabilizing it. Nek2. NIP2 was daughter-centriole-specific, but was also found in association with a stable microtubule network of cytoplasm. Ectopic NIP2 formed aggregates but was Key words: NIP2, Centrobin, Nek2, Centrosome, Mitosis, dissolved by Nek2 into small pieces and eventually Microtubule Introduction through the phosphorylation-induced displacement of C-Nap1 Phosphorylation is one of major control mechanisms used from the centriolar ends (reviewed in Fry, 2002). -
Retinitis Pigmentosa
View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Elsevier - Publisher Connector RETINITIS PIGMENTOSA 3231 3233 FREQUENCIES OF DIFFERENT FORMS OF AUrOSOMAL DOMINANT RETINITIS FINE MAPPING OF THE AUTOSOMAL RECESSIVE RETINITIS PlGMENTOSA AND A NEW LOCUS FOR adRP PIGMENTOSA LOCUS 136’12) ON CHROMOSOME IQ; EXCLUSION OF THE PHOSDUCIN GENE Ingihearn. CF.‘. Bardien. S.L. Tarttelin, E.E.‘, Greenberg, J.2, ACMaghtheh, M.‘, Ebenezer. N.‘. Keen. T.J.‘. Jav. M3. Bird. A.C.l. and Bhettacharva.S..S.’ VAN SOEST S’, TE NJJENHUIS S’, VAN DEN BORN LI’, 1. Departme;t of Mblecu~r &n&e, Inbtiie’of Ophthalmol~y:Lo”don, UK. BLEEKER-WAGEMAKERS EM’, SANKUIJL LA’, WESTERVELD 2. Department of Human Genetics, University c4 Cape Town, South Africa. A’, BERGEN AAB’. 3. Department cd Clinical Ophthalmology, Moorfields Eye Hospital. London, UK. m Seven loci for dominant retinitis pigmentoeehave been described in the literature. These include the Rhodopsin and Rdslperipherin genee. and anonymous loci identtfted only by linkage on 7p, 7q. aq, 17p and 19q. We wishedto estimatethe frequendesof the anonymous loci, and determinewhether Previously, we localised a gene for autosomal recessive retinitis any adRP loci remained to be found. pigmenfosa (ARRP) on chromosome la. in a laree Dutch pedigree The &@g& DNAe were colleded from twenty ftve adRP families. These were &igree was found to be clinically and genetic&y heterogeneous; the tested by linkage analyeis and mutetiin screening to determine the origin of the part that displayed Ii&age is phenotypically characterised by RF’ with phenotype in each family. -
Human PDCL (1-301, His-Tag) - Purified
OriGene Technologies, Inc. OriGene Technologies GmbH 9620 Medical Center Drive, Ste 200 Schillerstr. 5 Rockville, MD 20850 32052 Herford UNITED STATES GERMANY Phone: +1-888-267-4436 Phone: +49-5221-34606-0 Fax: +1-301-340-8606 Fax: +49-5221-34606-11 [email protected] [email protected] AR50426PU-N Human PDCL (1-301, His-tag) - Purified Alternate names: PHLP, Phosducin-like protein Quantity: 0.1 mg Concentration: 0.5 mg/ml (determined by Bradford assay) Background: PDCL, also known as phosducin-like protein, belongs to the phosducin family. Phosducin-like protein is a putative modulator of heterotrimeric G proteins. The protein shares extensive amino acid sequence homology with phosducin, a phosphoprotein expressed in retina and pineal gland. Both phosducin-like protein and phosphoducin have been shown to regulate G-protein signaling by binding to the beta-gamma subunits of G proteins. Uniprot ID: Q13371 NCBI: NP_005379 GeneID: 5082 Species: Human Source: E. coli Format: State: Liquid purified protein Purity: >90% by SDS - PAGE Buffer System: 20 mM Tris-HCl buffer (pH8.0) containing 20% glycerol, 0.1M NaCl, 1mM DTT Description: Recombinant human PDCL protein, fused to His-tag at N-terminus, was expressed in E.coli and purified by using conventional chromatography. AA Sequence: MGSSHHHHHH SSGLVPRGSH MGSHMTTLDD KLLGEKLQYY YSSSEDEDSD HEDKDRGRCA PASSSVPAEA ELAGEGISVN TGPKGVINDW RRFKQLETEQ REEQCREMER LIKKLSMTCR SHLDEEEEQQ KQKDLQEKIS GKMTLKEFAI MNEDQDDEEF LQQYRKQRME EMRQQLHKGP QFKQVFEISS GEGFLDMIDK EQKSIVIMVH IYEDGIPGTE AMNGCMICLA AEYPAVKFCK VKSSVIGASS QFTRNALPAL LIYKGGELIG NFVRVTDQLG DDFFAVDLEA FLQEFGLLPE KEVLVLTSVR NSATCHSEDS DLEID Molecular weight: 36.8 kDa (325aa) confirmed by MALDI-TOF Storage: Store undiluted at 2-8°C for one week or (in aliquots) at -20°C to -80°C for longer.